LSV Asset Management
CPIX icon

LSV Asset Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

LSV Asset Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-100,200
Closed -$450K – 905
2014
Q2 		$450K Hold
100,200
– – ﹤0.01% 746
2014
Q1 		$450K Hold
100,200
– – ﹤0.01% 724
2013
Q4 		$512K Hold
100,200
– – ﹤0.01% 710
2013
Q3 		$453K Hold
100,200
– – ﹤0.01% 742
2013
Q2 		$512K Buy
+100,200
New +$499K ﹤0.01% 713

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.25B AUM 19.46% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

LSV Asset Management's CPIX Position: Q3 2014 in Review

LSV Asset Management sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2014, closing a stake of 100,200 shares — an estimated $450K sold.

LSV Asset Management first reported a position in CPIX in Q2 2013 and held it in 5 quarters. The position peaked at $512K in Q4 2013. 45 funds tracked by Wall St. Rank hold CPIX as of Q3 2014.

  • LSV Asset Management reported no remaining Cumberland Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • LSV Asset Management sold 100,200 Cumberland Pharmaceuticals shares in Q3 2014, an estimated $450K.
  • LSV Asset Management first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • LSV Asset Management's Cumberland Pharmaceuticals position peaked at $512K in Q4 2013.
  • 45 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2014.

Based on LSV Asset Management's 13F filing for Q3 2014, filed 12 Nov 2014.